To include your compound in the COVID-19 Resource Center, submit it here.
Patient sample and mouse studies suggest agonizing FFAR1 could help treat temporal lobe epilepsy. In postmortem
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury